Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- AI company matching patients with clinical trials using digital pathology. $31.2M funded. Focuses on oncology trial recruitment through AI-powered pathology…
- Coverage: North America · Phase I–III
- Therapeutic focus: Oncology
- Scale: Small,Medium
Company fit
Best suited for
Oncology patient matching,Pathology-based screening,AI trial recruitment
Study fit
Niche but powerful for oncology sponsors wanting AI pathology to identify eligible patients.
Core strengths
- Unique AI pathology approach
- Oncology specialism
- $31.2M funded
Considerations
- Oncology only
- Early-stage company
Key facts
- Category
- AI / Machine Learning
- Geography
- North America
- Service model
- SaaS
- Vendor type
- Technology
- HQ
- United States